Literature DB >> 30172799

Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis.

Ovidiu Tatar1, Erika Thompson2, Anila Naz3, Samara Perez4, Gilla K Shapiro5, Kristina Wade6, Gregory Zimet7, Vladimir Gilca8, Monika Janda9, Jessica Kahn10, Ellen Daley11, Zeev Rosberger12.   

Abstract

Primary screening for cervical cancer is transitioning from the longstanding Pap smear towards implementation of an HPV-DNA test, which is more sensitive than Pap cytology in detecting high-risk lesions and offers greater protection against invasive cervical carcinomas. Based on these results, many countries are recommending and implementing HPV testing-based screening programs. Understanding what factors (e.g., knowledge, attitudes) will impact on HPV test acceptability by women is crucial for ensuring adequate public health practices to optimize cervical screening uptake. We used mixed methods research synthesis to provide a categorization of the relevant factors related to HPV primary screening for cervical cancer and describe their influence on women's acceptability of HPV testing. We searched Medline, Embase, PsycINFO, CINAHL, Global Health and Web of Science for journal articles between January 1, 1980 and October 31, 2017 and retained 22 empirical articles. Our results show that while most factors associated with HPV test acceptability are included in the Health Belief Model and/or Theory of Planned Behavior (e.g., attitudes, knowledge), other important factors are not encompassed by these theoretical frameworks (e.g., health behaviors, negative emotional reactions related to HPV testing). The direction of influence of psychosocial factors on HPV test acceptability was synthesized based on 14 quantitative studies as: facilitators (e.g., high perceived HPV test benefits), barriers (e.g., negative attitudes towards increased screening intervals), contradictory evidence (e.g., sexual history) and no impact (e.g., high perceived severity of HPV infection). Further population-based studies are needed to confirm the impact of these factors on HPV-based screening acceptability.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Barriers; Facilitators; Human Papillomavirus DNA Tests; Human papillomavirus; Mass Screening; Mixed methods; Psychology; Psychosocial; Review; Uterine Cervical Neoplasms

Mesh:

Year:  2018        PMID: 30172799     DOI: 10.1016/j.ypmed.2018.08.034

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  7 in total

1.  HPV Testing Behaviors and Willingness to Use HPV Self-sampling at Home Among African American (AA) and Sub-Saharan African Immigrant (SAI) Women.

Authors:  Adebola Adegboyega; Amanda T Wiggins; Lovoria B Williams; Mark Dignan
Journal:  J Racial Ethn Health Disparities       Date:  2021-11-15

2.  Does mailing unsolicited HPV self-sampling kits to women overdue for cervical cancer screening impact uptake of other preventive health services in a United States integrated delivery system?

Authors:  Hitomi Kariya; Diana S M Buist; Melissa L Anderson; John Lin; Hongyuan Gao; Linda K Ko; Rachel L Winer
Journal:  Prev Med       Date:  2021-11-17       Impact factor: 4.018

3.  Ensuring a Successful Transition From Cytology to Human Papillomavirus-Based Primary Cervical Cancer Screening in Canada by Investigating the Psychosocial Correlates of Women's Intentions: Protocol for an Observational Study.

Authors:  Gabrielle Griffin-Mathieu; Ben Haward; Ovidiu Tatar; Patricia Zhu; Samara Perez; Gilla K Shapiro; Emily McBride; Erika L Thompson; Laurie W Smith; Aisha K Lofters; Ellen M Daley; Juliet R Guichon; Jo Waller; Marc Steben; Kathleen M Decker; Marie-Helene Mayrand; Julia M L Brotherton; Gina S Ogilvie; Gregory D Zimet; Teresa Norris; Zeev Rosberger
Journal:  JMIR Res Protoc       Date:  2022-06-16

4.  Predictors, barriers and motivating factors for human papillomavirus vaccination and testing as preventive measures for cervical cancer: A study of urban women in Lagos, Nigeria.

Authors:  Adeyemi A Okunowo; Aloy O Ugwu; Jubril O Kuku; Adaiah P Soibi-Harry; Bolanle O Okunowo; Nneoma K Ani-Ugwu; Benedetto O Osunwusi; Muisi A Adenekan
Journal:  Prev Med Rep       Date:  2021-11-15

5.  Views of health professionals on risk-based breast cancer screening and its implementation in the Spanish National Health System: A qualitative discussion group study.

Authors:  Celmira Laza-Vásquez; Núria Codern-Bové; Àngels Cardona-Cardona; Maria José Hernández-Leal; Maria José Pérez-Lacasta; Misericòrdia Carles-Lavila; Montserrat Rué
Journal:  PLoS One       Date:  2022-02-04       Impact factor: 3.240

6.  Acceptability, simplicity, and relevance of the new human papillomavirus/DNA test among 35-year-old ever-married women in a district of Sri Lanka: focus group discussions.

Authors:  K C Perera; K N Mapitigama; T C Abeysena
Journal:  BMC Womens Health       Date:  2022-04-25       Impact factor: 2.742

7.  Assessing Canadian women's preferences for cervical cancer screening: A brief report.

Authors:  Patricia Zhu; Ovidiu Tatar; Ben Haward; Gabrielle Griffin-Mathieu; Samara Perez; Laurie Smith; Julia Brotherton; Gina Ogilvie; Zeev Rosberger
Journal:  Front Public Health       Date:  2022-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.